Clinical Trial Update: Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mesenchymal stem cells for systemic lupus erythematosus has completed enrollment (MiSLE).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED